埃索美拉唑和雷贝拉唑的区别是什么

Proton pump inhibitors (PPIs) are mainly used clinically to treat peptic ulcers, gastroesophageal reflux disease, Zoehler syndrome and upper gastrointestinal bleeding. They have now become the first-line drugs for abnormal gastric acid secretion and related diseases. Used in combination with amoxicillin, clarithromycin and other drugs to treat Helicobacter pylori infection. Rabeprazole and Nexium are commonly used clinical PPIs. What are the differences between these two drugs? Let’s take a look.

First generation PPIs: omeprazole, lansoprazole and pantoprazole. Mainly metabolized by hepatic drug enzyme CYP2C19, there are obvious individual differences, many drug interactions, slow onset of action, and weak acid suppression effect.

Second-generation PPIs: rabeprazole and esomeprazole, the proportions metabolized by CYP2C19 are reduced to varying degrees, individual differences are significantly reduced, and the acid-suppressing effect is also stronger.

Esomeprazole (Nexium) is a second-generation proton pump inhibitor, and omeprazole is a first-generation proton pump inhibitor. Esomeprazole is more effective than omeprazole. Both drugs have a good effect on inhibiting gastric acid secretion. They are both taken before meals. Esomeprazole (Nexium) and omeprazole are both proton pump inhibitors, which can inhibit gastric acid secretion, reduce gastric acid irritation of gastric mucosa, and promote gastric mucosal repair.

Esomeprazole (Nexium) can have a strong inhibitory effect on CYP2C19 and should be avoided in combination with clopidogrel; rabeprazole has no obvious effect on CYP2C19 and can be used in combination with clopidogrel.

These two drugs belong to the same category of drugs. Both are proton pump inhibitors that can effectively inhibit the secretion of gastric acid. Omeprazole is mainly used for duodenal ulcers and Zollinger-Ellison syndrome (gastrinoma), but can also be used for gastric ulcers and reflux esophagitis. Esomeprazole (Nexium) is used for the treatment of gastroesophageal reflux disease and erosive reflux esophagitis. It is a long-term maintenance treatment for cured esophagitis patients to prevent recurrence. Used in combination with appropriate antimicrobial therapy to eradicate Helicobacter pylori and heal duodenal ulcers associated with Helicobacter pylori infection to prevent recurrence of peptic ulcers associated with Helicobacter pylori infection. Patients can take it according to the doctor’s advice (Nexium).

Recommended hot articles: /newsDetail/79750.html